Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
71.35    -0.45 (-0.63%)
Bid:
71.60
Ask:
72.25
Spread: 0.65 (0.908%)
Market Cap: £264.83m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

28 Jan 2025 14:06

RNS Number : 9989U
RWS Holdings PLC
28 January 2025
 

28 January 2025

RWS Holdings plc

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

RWS Holdings plc ("RWS", the "Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces that options ("Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") were granted under the RWS Holdings plc Long Term Incentive Plan ("LTIP") on 24 January 2025 to PDMRs as outlined below.

The Options were granted with an exercise price per Ordinary Share of nil.

PDMR

Position

No. of Shares under Option

Benjamin Faes

Chief Executive Officer

1,397,357

Candida Davies

Chief Financial Officer

455,729

Jane Hyde

General Counsel and Company Secretary

174,669

Vasagi Kothandapani

President, Enterprise Services

177,979

Mark Lawyer

President, Regulated Industries & Linguistic AI

208,829

Christopher Lewey

Group Corporate Development Director

142,192

Amanda Newton

President, Global Content Services

181,021

Maria Schnell

Chief Language Officer

175,672

Jacqui Taylor

Chief People Officer

107,977

 

The extent to which the Options will vest will be dependent on RWS's total shareholder return ("TSR") over the period from 2 December 2024, being the date the CEO joined the Company, to the normal vesting date of 24 January 2028. A sliding scale of vesting percentages applies from zero vesting at 10% TSR p.a. to full vesting at 40% TSR p.a. over the performance period.

The performance condition for the Options provides for discretion to be retained by the Committee to reduce the level of vesting that would apply (including to nil vesting) if it considers there has not been an underlying improvement in the financial performance of the Company over the performance period or to counter windfall gains.

The Options have a normal vesting date of the third anniversary of the grant date and will ordinarily be forfeited in the event of cessation of employment ahead of the vesting date.

The Options granted to Benjamin Faes and Candida Davies are subject to a holding period condition under which any shares acquired under the Options (net of sales for tax and national insurance) must be retained until at least the fifth anniversary of the grant date.

Once vested, Options ordinarily will remain exercisable in respect of their vested shares until the tenth anniversary of the award's grant date.

This announcement is made in accordance with Article 19(3) of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

For further information, please contact:

RWS Holdings plc

Julie Southern, Chairman

Benjamin Faes, Chief Executive Officer

 

 

01753 480200

 

MHP (Financial PR advisor)

Katie Hunt / Eleni Menikou

 

rws@mhpgroup.com

020 3128 8100

07884 494112

Deutsche Numis (Nomad & Joint Broker)

Stuart Skinner / William Wickham

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Mike Burke / Milo Bonser

 

020 3207 7800

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 

For further information, please visit: www.rws.com.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

 

 

1. Benjamin Faes

2. Candida Davies

3. Jane Hyde

4. Vasagi Kothandapani

5. Mark Lawyer

6. Christopher Lewey

7. Amanda Newton

8. Maria Schnell

9. Jacqui Taylor

 

 

 

2

 

Reason for the notification

 

 

a)

 

Position/status

 

 

1. Chief Executive Officer

2. Chief Financial Officer

3. General Counsel and Company Secretary

4. President, Enterprise Services

5. President, Regulated Industries & Linguistic AI

6. Group Corporate Development Director

7. President, Global Content Services

8. Chief Language Officer

9. Chief People Officer

 

 

 

b)

 

Initial notification /Amendment

 

 

Initial Announcement

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

 

RWS Holdings plc

 

b)

 

LEI

 

 

213800YGBGTTSKUVK111

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

 

 

 

 

GB00BVFCZV34

 

Identification code

 

 

b)

 

Nature of the transaction

 

 

Grant of nil cost options under the RWS Holdings plc Long Term Incentive Plan.

 

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

8. Nil

9. Nil

1. 1,397,357

2. 455,729

3. 174,669

4. 177,979

5. 208,829

6. 142,192

7. 181,021

8. 175,672

9. 107,977

 

d)

 

Aggregated information

- Aggregated volume

3,021,425

- Price

Nil

e)

 

Date of the transaction

 

 

24 January 2025

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKFBKQBKDPDB
Date   Source Headline
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20239:30 amRNSAcquisition
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20234:15 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 202311:15 amRNSTransaction in Own Shares - Replacement
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSShare Repurchase Programme
12th Jun 20233:45 pmRNSDirector/PDMR Shareholding
8th Jun 20237:00 amRNSHalf-year Report
15th May 20233:10 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 202311:45 amRNSDirector/PDMR Shareholding
27th Apr 20235:13 pmRNSHolding(s) in Company
27th Apr 20233:25 pmRNSDirector/PDMR Shareholding
26th Apr 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSHalf Year Trading Statement
20th Apr 202310:15 amRNSCyber Incident
13th Mar 20237:00 amRNSUpdate on Silicon Valley Bank
22nd Feb 20234:30 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Statement
20th Feb 202310:00 amRNSDirector/PDMR Shareholding
10th Feb 202311:00 amRNSOption exercise and increase in share capital
27th Jan 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th Jan 20237:00 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSOption exercise and increase in share capital
5th Jan 202310:30 amRNSOption exercise and increase in share capital
3rd Jan 202310:00 amRNSDirectorate Change
15th Dec 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.